Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies, 21768-21769 [2021-08544]
Download as PDF
<![CDATA[
21768
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
Controlled substance
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
Phenmetrazine .....................................................................................................................................................................
Methylphenidate ..................................................................................................................................................................
Amobarbital ..........................................................................................................................................................................
Pentobarbital ........................................................................................................................................................................
Secobarbital .........................................................................................................................................................................
Glutethimide .........................................................................................................................................................................
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration
(FDA).
Nabilone ...............................................................................................................................................................................
1-Phenylcyclohexylamine ....................................................................................................................................................
Phencyclidine .......................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .........................................................................................................................
Phenylacetone .....................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ....................................................................................................................................
Alphaprodine ........................................................................................................................................................................
Anileridine ............................................................................................................................................................................
Cocaine ................................................................................................................................................................................
Codeine ...............................................................................................................................................................................
Etorphine HCl ......................................................................................................................................................................
Dihydrocodeine ....................................................................................................................................................................
Oxycodone ...........................................................................................................................................................................
Hydromorphone ...................................................................................................................................................................
Diphenoxylate ......................................................................................................................................................................
Ecgonine ..............................................................................................................................................................................
Ethylmorphine ......................................................................................................................................................................
Hydrocodone .......................................................................................................................................................................
Levomethorphan ..................................................................................................................................................................
Levorphanol .........................................................................................................................................................................
Isomethadone ......................................................................................................................................................................
Meperidine ...........................................................................................................................................................................
Meperidine-intermediate-A ..................................................................................................................................................
Meperidine intermediate-B ..................................................................................................................................................
Meperidine intermediate-C ..................................................................................................................................................
Metazocine ..........................................................................................................................................................................
Methadone ...........................................................................................................................................................................
Methadone intermediate ......................................................................................................................................................
Metopon ...............................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..................................................................................................................
Morphine ..............................................................................................................................................................................
Oripavine .............................................................................................................................................................................
Thebaine ..............................................................................................................................................................................
Dihydroetorphine .................................................................................................................................................................
Levo-alphacetylmethadol .....................................................................................................................................................
Oxymorphone ......................................................................................................................................................................
Noroxymorphone .................................................................................................................................................................
Phenazocine ........................................................................................................................................................................
Thiafentanil ..........................................................................................................................................................................
Piminodine ...........................................................................................................................................................................
Racemethorphan .................................................................................................................................................................
Racemorphan ......................................................................................................................................................................
Alfentanil ..............................................................................................................................................................................
Remifentanil .........................................................................................................................................................................
Sufentanil .............................................................................................................................................................................
Carfentanil ...........................................................................................................................................................................
Tapentadol ...........................................................................................................................................................................
Bezitramide ..........................................................................................................................................................................
Fentanyl ...............................................................................................................................................................................
Moramide-intermediate ........................................................................................................................................................
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytics purposes. Placement of
these drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
VerDate Sep<11>2014
18:15 Apr 22, 2021
Jkt 253001
Schedule
1631
1724
2125
2270
2315
2550
7365
II
II
II
II
II
II
II
7379
7460
7471
8333
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9260
9273
9300
9330
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
consistent with what is authorized in 21
U.S.C. 952(a)(2). Authorization will not
extend to the import of FDA-approved
or non-approved finished dosage forms
for commercial sale.
DEPARTMENT OF JUSTICE
William T. McDermott,
Assistant Administrator.
Bulk Manufacturer of Controlled
Substances Application: Rhodes
Technologies
[FR Doc. 2021–08535 Filed 4–22–21; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00086
Fmt 4703
Drug Enforcement Administration
[Docket No. DEA–825]
Drug Enforcement
Administration, Justice.
AGENCY:
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
ACTION:
Notice of application.
DEPARTMENT OF JUSTICE
Rhodes Technologies has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
SUMMARY:
The company plans to manufacture
the above-listed controlled substance(s)
in bulk for conversion and sale to
finished dosage form manufacturers. In
reference to drug codes 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic cannabidiol and
Tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration.
On April 19, 2021, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the District of Hawaii in the
lawsuit entitled United States v.
Kaanapali Land, LLC and Oahu Sugar
Company, LLC, Civil Action No. 1:21–
cv–00190.
The complaint filed in this case
alleges claims for response costs and
natural resource damages under the
Comprehensive Environmental
Response, Compensation, and Liability
Act (‘‘CERCLA’’) against Kaanapali Land
LLC and its bankrupt subsidiary, Oahu
Sugar Company, LLC (‘‘Oahu Sugar’’)
(together, ‘‘Settling Defendants’’). These
claims arise from the release and
threatened release of dioxins and
pentachlorophenol, among other
hazardous substances, at and from the
former Oahu Sugar pesticide mixing
facility (‘‘Site’’) located within the Pearl
Harbor Naval Complex Superfund Site.
Under the Consent Decree, Settling
Defendants will pay a total of $7.5
million to the United States
Environmental Protection Agency,
United States Department of the
Interior, the National Oceanic and
Atmospheric Administration, and the
Department of Defense, Department of
the Navy for Site cleanup and
environmental restoration projects. In
return, the Consent Decree grants
covenants not to sue to Settling
Defendants and related parties under
Sections 106, 107(a), and 113 of
CERCLA, Section 311(f)(4) of the Clean
Water Act, and Section 7003 of the
Resource Conservation and Recovery
Act (‘‘RCRA’’).
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States v. Kaanapali Land, LLC
and Oahu Sugar Company, LLC, D.J.
Ref. No. 90–11–3–08781/1. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
William T. McDermott,
Assistant Administrator.
To submit
comments:
Send them to:
[FR Doc. 2021–08544 Filed 4–22–21; 8:45 am]
By e-mail ......
pubcomment-ees.enrd@
usdoj.gov.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 22, 2021. Such persons
may also file a written request for a
hearing on the application on or before
June 22, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2021,
Rhodes Technologies, 498 Washington
Street Coventry, Rhode Island 02816,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana .......................
Tetrahydrocannabinols ...
Dihydromorphine ............
Methylphenidate .............
Oxycodone .....................
Hydromorphone ..............
Hydrocodone ..................
Levorphanol ....................
Morphine .........................
Oripavine ........................
Thebaine .........................
Oxymorphone .................
Noroxymorphone ............
Tapentadol ......................
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act
Drug
code
Schedule
7360
7370
9145
1724
9143
9150
9193
9220
9300
9330
9333
9652
9668
9780
I
I
I
II
II
II
II
II
II
II
II
II
II
II
BILLING CODE 4410–09–P
VerDate Sep<11>2014
18:15 Apr 22, 2021
Jkt 253001
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
21769
To submit
comments:
Send them to:
By mail .........
Assistant Attorney General,
US DOJ—ENRD, P.O. Box
7611, Washington, D.C.
20044–7611.
Under section 7003(d) of RCRA, a
commenter may request an opportunity
for a public meeting in the affected area.
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
Consent Decree upon written request
and payment of reproduction costs.
Please mail your request and payment
to: Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $10.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Lori Jonas,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2021–08477 Filed 4–22–21; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (BJA) Docket No. 1791]
Meeting of the Public Safety Officer
Medal of Valor Review Board
Bureau of Justice Assistance
(BJA), Office of Justice Programs (OJP),
Department of Justice.
ACTION: Notice of meeting.
AGENCY:
This is an announcement of a
meeting (via WebEx/conference call-in)
of the Public Safety Officer Medal of
Valor Review Board to consider a range
of issues of importance to the Board, to
include but not limited to: Membership/
terms; nomination eligibility; pending
2019–2020 recommendations; pending
2020–2021 nominations; program
marketing and outreach.
DATES: June 29, 2021, 1:00 p.m. to 2:00
p.m. EDT.
ADDRESSES: This meeting will be held
virtually using web conferencing
technology. The public may hear the
proceedings of this virtual meeting/
conference call by registering at last
seven (7) days in advance with Gregory
Joy (contact information below).
FOR FURTHER INFORMATION CONTACT:
Gregory Joy, Policy Advisor, Bureau of
SUMMARY:
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 86, Number 77 (Friday, April 23, 2021)]
[Notices]
[Pages 21768-21769]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08544]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-825]
Bulk Manufacturer of Controlled Substances Application: Rhodes
Technologies
AGENCY: Drug Enforcement Administration, Justice.
[[Page 21769]]
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Rhodes Technologies has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 22, 2021.
Such persons may also file a written request for a hearing on the
application on or before June 22, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2021, Rhodes Technologies, 498 Washington
Street Coventry, Rhode Island 02816, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dihydromorphine........................ 9145 I
Methylphenidate........................ 1724 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Levorphanol............................ 9220 II
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substance(s) in bulk for conversion and sale to finished dosage form
manufacturers. In reference to drug codes 7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetic cannabidiol and Tetrahydrocannabinol. No other
activity for these drug codes is authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08544 Filed 4-22-21; 8:45 am]
BILLING CODE 4410-09-P
